This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit September 7, 2016    SLAS2017    Moving? New job? Let SLAS know.      




SLAS2017 Registration is Now Open
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Register now to ensure your place at this pre-eminent annual event for life sciences discovery and technology professionals taking place Feb. 4-8 in Washington, DC. Deepest discounts are available to dues-paying SLAS members who register by Oct. 31.

Full conference registration includes scientific presentations, keynote speakers, exhibitor tutorials, Late Night with LRIG, SLAS Career Connections, exhibition, conference app, food functions, pocket guide and admission to Tuesday evening event at the Newseum. Add an SLAS2017 Short Course to maximize your time in DC.


SLAS ELN Reports: The Rich Legacy of Women in Science — Tenacity, Perseverance and Creativity
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A 300-year history of scientific discovery emerges in Rachel Swaby's 2015 book, Headstrong: 52 Women Who Changed Science — and the World. Sharing tenacity, perseverance and creativity, these scientists challenged obstacles and advanced knowledge in the fields of medicine, biology, genetics, physics and more.

"I wanted to write stories about people's lives — not just a bullet-point list of discoveries and accomplishments," says Swaby, a keynote presenter at SLAS2017. She hopes that the wit and wisdom of her subjects will capture the SLAS audience in DC as enthusiastically as they have captured the many readers of her book. Read more in the SLAS Electronic Laboratory Neighborhood e-zine feature article.

Sponsored Content

SLAS Europe Call for Projects: Academic Scientists and Start-Ups
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Project proposals on potential therapeutic modalities are requested for presentation to Pharma Open Innovations groups, infrastructure providers, CROs and public funding bodies from across Europe at the SLAS Translating Research Ideas into Future Therapeutics Conference, Nov. 29-30, Leuven, Belgium. Proposals are due Sept. 16. If selected, you will have the opportunity to:
  • Present the key scientific findings underlying your existing therapeutic asset or planned program
  • Communicate current asset status and requirements for enabling collaborations including access to infrastructures and CRO capabilities
  • Outline future program objectives and what is needed to achieve these in terms of financing and structural support
  • Receive clear direction on the expectations of venture capitalists and pharma and essential guidance on achieving successful project execution and navigating the complex pathway toward clinical stages

Welcome to RAD Source
Since 1997 Rad Source Technologies has been the expert in providing renewable, non-isotope, ionizing radiation replacements for self-shielded gamma irradiators. Currently, there are over 300 renowned hospital, university, and pharmaceutical research institutions using Rad Source X-ray technology. To find out more about our equipment, select your application and you will find equipment specifications, literature references, white papers, training videos, discussion forums, as well as other helpful info.

SLAS Announces New Fellow Member Category
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS Fellow Member is an invitation‐only distinction earned by a combination of membership tenure, professional experience and contribution of technical expertise and volunteer service to SLAS and its global membership community.

"Any success SLAS has achieved is primarily a result from the knowledge‐sharing, loyal support and exceptional volunteer leadership from among our member ranks," said SLAS President Richard Eglen. "Originally proposed by my predecessor and SLAS Immediate Past President Dean Ho, we believe the SLAS Fellow Member Program is an ideal way to celebrate the significant and lasting contributions of those who made SLAS the premier Society it is today, one based on peer‐driven scientific education, a collaborative spirit of open sharing and selfless example of serving others and our professions."


Advances in MALDI Mass Spectrometry for Drug Discovery: JBS Special Issue Call for Papers Due Sept. 30
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Guest editors Shannon Cornett, Ph.D., of Bruker and Michael Scholle, M.S., M.B.A. of SAMDI Tech invite your manuscript proposals (abstracts) by Sept. 30 for this 2017 special issue. Proposals will be used to select papers for submission and peer review.

Areas of interest include high-throughput MALDI applications; use of MALDI in enzyme characterization; applications of MALDI and MALDI imaging for metabolite detection and screening and for drug distribution studies; MALDI applications for characterizing small molecules; applications of MALDI imaging for early detection of toxicity; and MALDI applications for profiling cells, cell lines and biochemical samples and for determining metabolism and kinetics.

Accelerate your NGS Success

Fast, accurate sequencing begins with automated NGS Sample Prep from Agilent.

Netzeband Wins SLAS2017 Registration at LRIG Bay Area Meeting
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Jeff Netzeband of Biolin Scientific was the lucky winner of a full conference registration to SLAS2017 drawn at the LRIG Bay Area Chapter Meeting Sept. 1 in South San Francisco. The LRIG event featured four presenters from Circuit Therapeutics, Genentech and the University of California at San Francisco exploring trends in neuroscience technology, 20-plus exhibitors, lunch, networking and more than 100 attendees.

Netzeband is pictured here with SLAS Senior Manager Communications Lynn Valastyan.

Sponsored Content


Construction of Covalent Organic Nanotubes by Light-Induced Cross-Linking of Diacetylene-Based Helical Polymers
Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Organic nanotubes (ONTs) are tubular nanostructures composed of small molecules or macromolecules that have found various applications including ion sensor/channels, gas absorption, and photovoltaics. While most ONTs are constructed by self-assembly processes based on weak noncovalent interactions, this unique property gives rise to the inherent instability of their tubular structures. Herein, we report a simple "helix-to-tube" strategy to construct robust, covalent ONTs from easily accessible poly(m-phenylene diethynylene)s (poly-PDEs) possessing chiral amide side chains that can adopt a helical conformation through hydrogen-bonding interactions. More

New Method Makes Building 'One-Handed' Drugs Easier Than Ever    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Chemists at The Scripps Research Institute (TSRI) have invented a new technique for constructing one-handed or "chiral" drug molecules. The new method is already being adopted by pharmaceutical researchers. "This new process provides an entirely new pathway for constructing one of the 'cornerstones' of chiral molecules, namely, beta-chiral centers, and should accelerate the development of chiral drugs," said senior author Jin-Quan Yu, Frank and Bertha Hupp Professor in the Department of Chemistry at TSRI. The new method is a major addition to the molecule-construction toolkit. More

Programmable, Pneumatically Actuated Microfluidic Device with an Integrated Nanochannel Array To Track Development of Individual Bacteria
Analytical Chemistry    Share    Share on FacebookTwitterShare on LinkedinE-mail article
We describe a microfluidic device with an integrated nanochannel array to trap individual bacteria and monitor growth and reproduction of lineages over multiple generations. Our poly(dimethylsiloxane) device comprises a pneumatically actuated nanochannel array that includes 1,280 channels with widths from 600 to 1000 nm to actively trap diverse bacteria. Integrated pumps and valves perform on-chip fluid and cell manipulations that provide dynamic control of cell loading and nutrient flow, permitting chemostatic growth for extended periods of time (typically 12 to 20 hours). More

War on Cancer May Shift to Containment Strategy
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The war on cancer may become a cold war, now that a new drug-delivery system has shown that it is possible to combine careful targeting with small, frequent dosing. With such a system, it may be possible to avoid the usual rollback approach, the administration of "maximum tolerable doses" of chemotherapeutic drugs. Because all-out hostilities against cancer are hard to sustain, and may require rest periods that allow cancer to develop resistance, low-level conflict, patiently sustained, may actually be more effective. More

Opinion: How to Avoid Legal Problems in Collaborative Research
The Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The path from the discovery of the CRISPR/Cas mechanism as part of bacteria's adaptive immune system to the use of this pathway in the food industry and later as a breakthrough gene-editing tool is a good illustration of the power of collaboration among scientists across disciplines. Yet CRISPR's development also serves as a salient warning of how failing to assign clear and up-front ownership of intellectual property can result in prolonged and costly legal friction. More

New Vaccine Coalition Aims to Ward off Epidemics
Science Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new public-private coalition that aims to derail epidemics by speeding development of vaccines has now hung its shingle with the backing of the Wellcome Trust and the Bill & Melinda Gates Foundation. The Coalition for Epidemic Preparedness Innovations, which launched its website Sept. 2, grew out of the widespread conviction that vaccines languishing in R&D could have prevented the recent Ebola epidemic in West Africa that killed more than 11,000 people. More

Academia and Industry Collaborate on $15 Million Initiative to Study Bipolar Disorder, Schizophrenia
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The National Institute of Mental Health announced a $15.4 million initiative that will bring academia and industry together using induced pluripotent stem cell technology to delve into the cellular underpinnings of schizophrenia and bipolar disorder and identify or develop drugs to treat the illnesses. Hongjun Song, Ph.D. of Johns Hopkins University School of Medicine and Rusty Gage Ph.D., of the Salk Institute for Biological studies, will co-lead the consortium, which is made up of four academic institutes and two industry partners. More

Ancient Fossils in Greenland Suggest Evidence for Microbial Life From 3.7 Billion Years Ago
Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Melting snow in Greenland has unveiled what might be the world's oldest fossils. On the newly exposed, 3.7 billion-year-old rock, researchers led by Allen Nutman of the University of Wollongong found conical geological formations called stromatolites (see dotted lines), deposits made by ancient microbial life. If confirmed, this finding — characterized by trace element, mineral chemistry, and other analyses — pushes back the geological evidence for life by 200 million years. More


Postdoctoral Associate in Translational Immunobiology
Duke University School of Medicine
US – NC – Durham

Microbiologist – Technical Leadership Program
Sealed Air
US – NC – Charlotte

Assistant or Associate Member Faculty, Division of Human Biology
Fred Hutchinson Cancer Research Center
US – WA – Seattle

Search Jobs at SLAS Career Connections


SLAS Point-to-Point
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Dennis Hall, Executive Editor, 469.420.2656   
Contribute news

This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

SLAS Terms of Use Policy
Recent issues

Aug. 31, 2016
Aug. 24, 2016
Aug. 17 , 2016
Aug. 10, 2016

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063